Concepedia
Statistics
Publications
13
Citations
1.7K
H-Index
12
Active since
1990
Affiliations
Ludwig Cancer Research(Current)
UCLouvain
de Duve Institute
Walloon Excellence in Lifesciences and Biotechnology
Cliniques Universitaires Saint-Luc
Claude Wildmann is an author at Ludwig Cancer Research specializing in immunology, life sciences, and cancer immunology.
Publications per year
1990–2024
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
Pascale Boël, Claude Wildmann, Marialuisa Sensi et al. · Immunity · 1995 · 590 citations · Full text
Life Sciences, Immunology, Molecular Biology +16
Autologous cytolytic T lymphocytes recognize a MAGE‐1 nonapeptide on melanomas expressing HLA‐Cw* 1601
Pierre van der Bruggen, Jean‐Pierre Szikora, Pascale Boël et al. · European Journal of Immunology · 1994 · 231 citations
Life Sciences, Immunology, Oncology +17
Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration
Mónica Gordón‐Alonso, Thibault Hirsch, Claude Wildmann et al. · Nature Communications · 2017 · 183 citations · Full text
Medicine, Immunology, Oncology +17
Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.
Catherine Sibille, Patrick Chomez, Claude Wildmann et al. · The Journal of Experimental Medicine · 1990 · 151 citations · Full text
Life Sciences, Immunology, Molecular Biology +17
A tyrosinase nonapeptide presented by HLA‐B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes
Vincent Brichard, Jean Herman, Aline Van Pel et al. · European Journal of Immunology · 1996 · 135 citations
Life Sciences, Immunology, Oncology +16
1–5 of 13